A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2004
10/20/2004	EP1468013A2 Conformationally constrained c-backbone cyclic peptides
10/20/2004	EP1468012A1 Biomolecule transduction motif mph-1-btm and the use thereof
10/20/2004	EP1468011A1 Biomolecule transduction motif sim-2-btm and the use thereof
10/20/2004	EP1468010A1 Solid salts benzazepine compounds and their use in the preparation of pharmaceuticals compounds
10/20/2004	EP1468008A2 MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) PROMOTER POLYMORPHISM IN INFLAMMATORY DISEASE
10/20/2004	EP1468007A2 Pseudonucleotide comprising an intercalator
10/20/2004	EP1467989A1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatitis c virus infection
10/20/2004	EP1467969A2 Dna minor groove binding compounds
10/20/2004	EP1467768A1 Increasing electro-gene transfer of nucleic acid molecules into host tissue
10/20/2004	EP1467765A2 Combination therapy for the treatment of bacterial infections
10/20/2004	EP1467759A2 Compositions and methods related to tim-3, a th1-specific cell surface molecule
10/20/2004	EP1467750A1 Orodispersible pharmaceutical composition comprising perindopril
10/20/2004	EP1467749A1 Thrombin derived peptides for promoting cardiac tissue repair
10/20/2004	EP1467748A1 Stimulation of bone growth and cartilage formation with thrombing peptide derivatives
10/20/2004	EP1467747A2 Use of dimer-specific nuclear localisation signal peptides (dsnls) derived from the stat dna binding domain
10/20/2004	EP1467746A2 Systems and methods for treating patients with collagen-rich material extracted from adipose tissue
10/20/2004	EP1467719A2 Method and device for feeding living cells into a biological body fluid
10/20/2004	EP1467717A1 Stable pharmaceutical compositions comprising ace inhibitor(s)
10/20/2004	EP1467716A2 Polytartrate composition
10/20/2004	EP1467710A2 Pharmaceutical composition comprising an oil/water/oil double microemulsion incorporated into a solid support
10/20/2004	EP1467624A2 Methods of inducing or enhancing connective tissue repair
10/20/2004	EP1465643A4 Methods and compositions for oxygen transport comprising a high oxygen affinity
10/20/2004	EP1404180A4 Peripheral blood fibrocytes differentiation pathway and migration to wound sites
10/20/2004	EP1232252A4 Reversibly inactivated acidified plasmin
10/20/2004	EP1230236B1 Compound with growth hormone releasing properties
10/20/2004	EP1207892B1 Use of oyster flesh enzymatic hydrolysates for preparing compositions eliminating free radicals
10/20/2004	EP1206276B1 Tissue volume reduction
10/20/2004	EP1198477B1 Prolactin-releasing peptide and use in treating pain
10/20/2004	EP1171143B1 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same
10/20/2004	EP1151008B1 Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant
10/20/2004	EP1135112B1 An oral formulation for gastrointestinal drug delivery
10/20/2004	EP1121142B1 Angiogenically effective unit dose of fgf-2 and use thereof
10/20/2004	EP1117416B1 Plant extracts for the treatment of increased bone resorption
10/20/2004	EP1043028B1 Phytase for preventing or treating mastitis
10/20/2004	EP1032592A4 Antimicrobial peptides
10/20/2004	EP0959895B1 Peptides responsive to antibodies against a consensus peptide of the cs4-cfa/i family proteins
10/20/2004	EP0939796A4 Uses of oncofetal antigen specific cd4, cd8 cytotoxic and suppressor t cells and interleukin-10
10/20/2004	EP0904107B1 Immunoglobin-like domains with increased half lives
10/20/2004	EP0831860B1 Allogeneic cell therapy for cancer following allogeneic stem cell transplantation
10/20/2004	EP0778891B1 Monoclonal recombinant anti-rhesus d (d7c2) antibody
10/20/2004	EP0771214B1 Treatment and prevention of helicobacter infection
10/20/2004	EP0734451B1 ENTEROTOXINS OF SHIGELLA FLEXNERI 2a
10/20/2004	EP0732939B1 Preparation and use of immunoconjugates comprising a VL-chain glycosylated at the Asn in position 18
10/20/2004	EP0658113B1 Isolated nonapeptide derived from mage-3 gene and presented by hla-a1, and uses thereof
10/20/2004	CN1538852A Mixtures of growth horomone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof and methods of making same
10/20/2004	CN1538851A Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, used thereof and method of making same
10/20/2004	CN1538850A BMP Binding proteins for use in bone or cartilage regenearation
10/20/2004	CN1538849A Use of long PENTRAXIN PTX 3 for treating female infertility
10/20/2004	CN1538848A Novel Benzo-fused heterocycles
10/20/2004	CN1538846A Oral administration of 6-hydroxy-oxymorphone for use as antalgesic
10/20/2004	CN1538809A Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, used thereof and methods of making same
10/20/2004	CN1537939A Method for producing recombinaton urokinase
10/20/2004	CN1537938A New earthoworm plasmin and its preparation method
10/20/2004	CN1537866A Heteroprotein of melanoma epi (Mage-1, HLA-Al) and bacteriophage coat protein and its application
10/20/2004	CN1537633A Protein having antitumor function, and high performance expression in vitro
10/20/2004	CN1171997C Modified TLE-2-receptor ligands
10/20/2004	CN1171902C Antisercretory factor petides regulating pathological permeability changes
10/20/2004	CN1171900C Novel, ubiquitous potassium-channel proteins and genes for the same
10/20/2004	CN1171899C Structure and usage of plasminogen activator (TPA) mutant
10/20/2004	CN1171852C Method for inactivating virus in bio-composition
10/20/2004	CN1171638C Sugar chain-recognizing antibody and remedy for infection with HIV
10/20/2004	CN1171635C Topical composition containing human epidermal growth factor
10/19/2004	US6807421 Method for controlling connections to a mobile station
10/19/2004	US6806360 Nucleic acids encoding human tissue factor inhibitor
10/19/2004	US6806355 Purification of preferential globulin; obtain sample containing globulin, expose to ion exchange column, filter and recover globulin
10/19/2004	US6806351 Nucleotide sequences coding proteins for use in the diagnosis and treatment of hematopoietic or immune disorders
10/19/2004	US6806279 For therapy of autoimmune diseases such as rheumatoid arthritis, multiple sclerosis, uveitis, and psoriasis, allograft rejection, and graft-versus-host disease
10/19/2004	US6806258 Antisense oligonucleotide modulation of raf gene expression
10/19/2004	US6806255 Compounds and methods for modulating adhesion molecule function
10/19/2004	US6806254 An isolated polynucleotide containing a nucleotide sequence with a specific sequence, translated protein coding protion, mature protein coding protion, extracellular portion or the active domain, codes a polypeptide
10/19/2004	US6806253 Therapeutic and preventive anti-bacterial vaccine complex
10/19/2004	US6806252 Synergistic mixture of casein polypeptide to promote calcium absorption and genistein which inhibits bone resorption and promotes osteogenesis; prevent decrease in bone density and onset of osteoporosis
10/19/2004	US6806251 Method of treating pain
10/19/2004	US6806084 Comprises dna/lipid carrier complexes for transfection; for modulating the genotype and phenotype into two or more tissues following systemic administration; for gene therapy
10/19/2004	US6806073 For therapeutic, diagnostic, and pharmacogenomic applications
10/19/2004	US6806069 Ubiquinone composition and methods related thereto
10/19/2004	US6806063 Protein conjugate for use in the treatment of blood disorder
10/19/2004	US6806061 G protein-coupled receptor gene and methods of use therefor
10/19/2004	US6806059 Nucleotide sequences coding enzymatic polypeptide for use innthe treatment of asthma, and for use in laundry detergent and stain removers
10/19/2004	US6806054 Non-endogenous, constitutively activated known G protein-coupled receptors
10/19/2004	US6805879 Made with a hydrophilic polymer; microencapsulation of proteins, peptides, viruses, bacteria, cells; diagnosis kits
10/19/2004	US6805869 Cellular vaccines and immunotherapeutics and methods for their preparation
10/19/2004	US6805865 Compositions and methods for treating cancer and hyperproliferative disorders
10/19/2004	US6805864 Type I angiotensin II receptor specific monoclonal antibodies and hybridomas
10/19/2004	US6805863 Comprises antibodies/proteins providing inhibition of prothrombinase; treatment and prevention of bacterial and viral infections, allograft/xenograft rejection, glomerulo-nephritis, cancer, gastrointestinal diseases, and fetal loss
10/19/2004	US6805858 Methods for the administration of adenovirus p53
10/19/2004	CA2323096C Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
10/19/2004	CA2238574C Targeted cytotoxic anthracycline analogs
10/19/2004	CA1341459C Modified fibrinolytic enzymes
10/18/2004	CA2426115A1 Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots
10/14/2004	WO2004087962A1 Detection of hpv-induced invasive cancers and their precursor lesions with invasive potential
10/14/2004	WO2004087930A1 Adenovirus replication-competent vectors expressing trail
10/14/2004	WO2004087922A1 Isolation of a novel blue copper protein gene from rice combating salinity stress and possessing agronomic, nutraceutical and cosmaceutical properties
10/14/2004	WO2004087921A1 Human solid cancer antigen peptides, polynucleotides encoding the same and utilization thererof
10/14/2004	WO2004087920A1 Antisense oligonucleotides (odn) against smad7 and uses in medical field thereof
10/14/2004	WO2004087917A1 Thioredoxin modification
10/14/2004	WO2004087915A1 Seb modification and preventive/remedy for diseases with immune abnormality contianing the same
10/14/2004	WO2004087912A1 Inhibitor proteins of a protease and use thereof
10/14/2004	WO2004087875A2 Nucleic acid-associated proteins
10/14/2004	WO2004087873A2 Methods of treating xerostomia and xerophthalmia

1 ... 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 ... 3163